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Abstract Inadequate dietary fiber intake is common in mod-
ern diets, especially in children. Epidemiological and experi-
mental evidence point to a significant association between a
lack of fiber intake and ischemic heart disease, stroke athero-
sclerosis, type 2 diabetes, overweight and obesity, insulin
resistance, hypertension, dyslipidemia, as well as gastrointes-
tinal disorders such as diverticulosis, irritable bowel disease,
colon cancer, and cholelithiasis. The physiological effects of
fiber relate to the physical properties of volume, viscosity, and
water-holding capacity that the fiber imparts to food leading
to important influences over the energy density of food.
Beyond these physical properties, fiber directly impacts a
complex array of microbiological, biochemical, and neuro-
hormonal effects directly through modification of the kinetics
of digestion and through its metabolism into constituents such
as short chain fatty acids, which are both energy substrates
and important enteroendocrine ligands. Of particular interest
to clinicians is the important role dietary fiber plays in glucor-
egulation, appetite, and satiety. Supplementation of the diet
with highly functional fibers may prove to play an important
role in long-term obesity management.
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Introduction
The “eat less and exercise more” paradigm has proven to be
of little value in the clinical management of the obese
patient. Likewise, treatments that rely upon complex or
rigorous dietary plans tend to result in poor long-term bene-
fits with patients typically drifting back to their old habits
once the novelty of the diet has worn off. Clinicians are
increasingly assisting obese patients in the establishment of
more achievable long goals, including the avoidance of
further weight gain as a realistic end point in some patients.
Rather than complex dietary regimens, most patients re-
spond more favorably to incorporating eating strategies that
help them achieve and maintain a sense of satiety while
reducing their caloric intake. Significantly increasing the
consumption of dietary fiber to reduce the caloric density
of food and reduce the glycemic impact of the food is
generally considered to play an important, if not essential,
part of long-term weight management [1].
What Is Dietary Fiber?
Dietary fiber is a non-starch polysaccharide in (mostly) plant
food that is poorly digested by humans. Based on a recent US
government consensus report, fiber can exist as dietary fiber
(naturally occurring in food), or functional fiber (added during
the processing or preparation of food or consumed separately
as a supplement) [2]. Fiber can be insoluble or soluble in
water. Insoluble fibers include cellulose, hemicellulose, and
lignins, whereas soluble fibers include various gums, pectins,
β-glucans, oligosaccharides, resistant dextrans, and resistant
starches. Chitin and chitosan are indigestible amino-
polysaccharides that are found in or are derived from the
exoskeletons of arthropods such as crabs and lobster, as well
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as the cell walls of most fungi, and could functionally be
regarded as fiber, although they are not recognized as fiber
by most regulatory authorities. The distinction between solu-
ble and insoluble fibers is due to the chemical properties of the
fiber, resulting in its tendency to absorb water. Various phys-
icochemical properties of fiber (viscosity, water-holding ca-
pacity, cation exchange capacity, adsorption of organic
materials, and fermentability) are now thought to be funda-
mental to its beneficial physiologic effects. The Institute of
Medicine has proposed a new definition of dietary fiber that
encompasses both its physical characteristics and its physio-
logic effects in humans [3]. A fiber’s viscosity, its water-
holding capacity, and its fermentability are the chief determi-
nates of fiber’s physiologic effects.
The regulatory classification of fiber varies considerably
in different countries. The Codex Alimentarius Commis-
sion of the World Health Organization has defined dietary
fiber upon analytic methods rather than its physical or
physiologic characteristics [4].
Sources
The typical Western diet is generally lacking in sufficient
dietary fiber, being composed principally of refined grains
and other highly digestible sources of starch, sugar, various
fats, and animal products. Children in particular are com-
monly fiber deficient, with daily intakes often under 5 g and
with little soluble fiber. Likewise, many adults in Western
society consume 5 to 10 g of fiber daily, as opposed to the
35 to 50 g that is considered desirable for optimal health [5].
Moreover, because most fiber in the Western diet is derived
from cereal grains, the intake of viscous soluble fiber is
typically inadequate.
A diet focusing on a large intake of vegetables and fruits as
well as unrefined whole grains and legumes should be the
foundation of a healthy lifestyle. With this “whole-foods”
based diet, it is certain that dietary fiber intake will substan-
tially increase [6]. Unfortunately, only a minority of the pop-
ulation, particularly children, are likely to adopt a largely
whole-foods diet anytime in the near future. Because of this,
efforts are underway to establish effective means to fortify the
Western diet with dietary fiber through the use of functional
fibers (various fibers as food additives or ingredients as well
as the use of readily accepted fiber supplements).
Health Effects
There is compelling epidemiologic and experimental data
associating numerous disorders, at least in part, to a lack of
dietary fiber. Ischemic heart disease, stroke atherosclerosis,
type 2 diabetes, overweight and obesity, insulin resistance,
hypertension, dyslipidemia, as well as gastrointestinal dis-
orders such as diverticulosis, irritable bowel disease, colon
cancer, and cholelithiasis are just a few of the many con-
ditions that seem to be influenced by the adequacy of dietary
fiber intake [7, 8].
Numerous studies have demonstrated that certain fibers
decrease the glycemic response to food, promote satiety,
lower serum cholesterol, promote bowel regularity, positive-
ly influence colonic microflora, provide nutritional sub-
strates for colonic mucosal cells, improve mucosal barrier
function, as well as aid in the sequestration and elimination
of toxic and carcinogenic dietary and environmental com-
pounds. These and other effects constantly interplay to
increase or decrease the development of a wide range of
health conditions.
Viscous dietary fibers have been correlated with moder-
ation in blood glucose and cholesterol concentrations, pro-
longed gastric emptying, and slower transit time through the
small intestine [9]. Among viscous fibers, fermentability is
mostly associated with large bowel function. Rapidly fer-
mented fiber sources provide substrates for short-chain fatty
acid (SCFA) production by microflora in the large bowel,
whereas slowly or incompletely fermented fiber sources
improve bowel health by promoting laxation, reducing
colonic transit time, and increasing stool weight [10].
Mechanisms of Action of Dietary Fiber
Dietary fiber exerts its effects through an interaction between
the physical properties it imparts to foods accompanied by a
complex array of microbiological, biochemical, and neuro-
hormonal influences. Dietary fiber can have a strong influence
on the palatability of food, and may require longer periods of
mastication before swallowing, thus influencing ingestive
behavior. In the stomach, fiber affects the volume and viscos-
ity of food, which has a highly significant effect on satiety
[11]. This “volumetric” effect on food promotes a sense of
fullness and a delay in gastric emptying, which tends to
naturally result in a decrease in caloric intake. Various fibers
differ dramatically in their ability to impart volume and vis-
cosity to foods, and it has been shown that simple distention of
the gastric antrum by soluble, viscous fibers leads to a sensa-
tion of satiety that tends to promote cessation of eating during
meal time [12]. Viscous fiber has also been shown to slow
gastric emptying, thus resulting in a prolongation of the me-
chanical distention of the stomach [13]. As well, viscous fiber
consumption results in a delayed postprandial rise of ghrelin,
the principle peripheral orexigen that promotes meal initia-
tion. This delay in the pre-meal elevation of ghrelin is thought
to result from slowed absorption of glucose and amino acids
and a resultant increase in the delivery of these nutrients to the
jejunum and ileum [14].
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Viscosity of Fiber
Viscosity as related to dietary fiber refers to the ability of
some polysaccharides to thicken or form gels when mixed
with fluids resulting from physical entanglements and hy-
drophilic interactions among the polysaccharide constitu-
ents within the fluid or solution [15]. Gums, pectins, and
β-glucans make up the majority of viscous dietary fibers.
Apples, legumes, and oats are common dietary sources of
viscous fibers. The viscosity that a fiber imparts to the
gastric and small intestinal contents is directly correlated
with the ability of the fiber to reduce postprandial glycemic
response, promote satiety, decrease serum cholesterol, and
decrease serum uric acid [16, 17••]. The viscosity of fiber is
also thought to play an important role in the augmentation of
gut mucosal protection through the stimulation of enteral
mucus production and goblet cell hypertrophy and replica-
tion [18]. Additionally, those viscous fibers that are largely
fermented by colonic microflora exert a wide array of phys-
iologic effects through the production of SCFAs (the prin-
ciple energy substrates of colonocytes), the promotion of
beneficial colonic microbial populations, and the augmenta-
tion of important gut-derived peptide hormones.
The viscosity of fiber is best measured by methods that
quantify a hydrated fiber’s internal friction and its ability
to resist flow. Viscosity is usually expressed in units of
millipascal seconds or centipoise [19]. Other factors, such
as shear stress (e.g., mastication, peristalsis), acid pH,
dilution, and chemical components of food determine the
real viscosity that a fiber will impart to food rather than
just its in vitro viscosity.
The concept of the glycemic index (GI) came about
through the work of Jenkins et al. [20] as they exam-
ined the impact of viscous fiber ingestion on glucose
tolerance. It is now generally accepted that the GI of a
carbohydrate-containing food is directly correlated to
the viscosity of that food after ingestion. Viscous fibers
increase small intestinal transit time, thus decreasing
the speed of macronutrient digestion and absorption
[14]. Along with changes in absorptive rate, prolonging
the exposure of the enteral mucosa to macronutrients
augments the liberation of anorexigenic peptides. Fat
and protein in the proximal small bowel stimulate the
release of cholecystokinin (CCK), which promotes
acute postprandial satiety. As well, the elevated deliv-
ery of carbohydrates to the distal small intestine, stim-
ulate the release of the anorexigenic peptides glucagon-
like peptide 1 (GLP-1) and peptide YY (PYY) in a
manner perhaps akin to that which occurs (on a greater
scale) from the malabsorption accompanying gastric
bypass surgery [21, 22•]. These mechanisms tend to
promote satiety between meals and result in a delay
in the onset of hunger.
Water-Holding Capacity and Energy Density
The ability of a fiber to absorb and hold on to water as it
transits the gut is key factor that contributes to its func-
tional effects. Soluble fibers have the capacity to create a
stable gel that results in stomach volume being occupied
and a sense of satiety created without the addition of
significant calories. This concept has been referred to as
“caloric displacement,” meaning that the consumption of
low-calorie-density food or supplemental fiber can result
in the achievement of satiety with a caloric intake that is
less than if the food consumed was higher in caloric or
energy density.
A food’s energy density consists of the net quantity of
calories in a particular weight of food (usually expressed
as kcal/g). Several strategies have been employed involv-
ing the addition of substantial amounts of low-energy-
density foods to a meal plan. For instance, consuming a
high-fiber, low-energy-density soup as a “preload” before
the rest of a meal significantly reduces the ad libitum
food intake for that meal while increasing feelings of
satiety [23]. Similarly, consuming a large, low-energy-
density salad at the onset or during a meal reduces the
total ad libitum consumption of food for that meal [24••].
Recently, it has been demonstrated that a variety of high-
fiber vegetables can be added to acceptable foods result-
ing in a significant decrease in the calorie density of the
food without a negative impact upon the palatability of
the food, even with children [25••]. Consuming function-
al fiber supplements prior to or with meals can also
reduce the caloric density of meals and promote satiety.
As an example, our research group recently studied the
effect of adding a highly viscous functional fiber supple-
ment (PGX®) to each meal with food, or in liquid meal
replacements in women on a low-calorie diet. In this
double-blind placebo-controlled trial, each 5-g dose of
the highly viscous fiber was estimated to hold approxi-
mately 1 L of water in its passage through the stomach
and small intestine, essentially adding 3 L or over 6 lb of
non-caloric food mass to the daily food intake. In this
study we were able to show that the viscous fiber sup-
plement significantly reduced hunger feelings and pro-
moted satiety during a period of significant caloric
reduction (Fig. 1) [26••].
Those who work in the field of obesity management
generally accept the necessity of teaching patients prac-
tical strategies that promote the consumption of low-
calorie-density, highly volumetric foods in the dietary
management of overweight and obesity [27••, 28, 29].
Functional fiber supplements may play a significant role
in assisting patients in the achievement of consistent
reductions in the energy density of their diets, especially
during periods of significant caloric reduction.
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Prebiotic Effects of Fiber
It is increasingly recognized that certain forms of fiber are
fermentable, providing important metabolic substrates in the
metabolism of gut flora. By definition, humans lack the
enzymes specific to digest fiber. In the case of insoluble
fiber, most gut microbes cannot utilize this as an energy
source, and so it is typically excreted without any molecular
alteration other than by forming a surface for the adsorption
of water, organic matter, and cations. Soluble fibers vary in
their fermentability and in the specific microbes that can
utilize them as substrates. The term “prebiotic” was coined
by Gibson and Roberfroid [30, 31] in 1995, and was defined
as an indigestible carbohydrate that is fermentable in the
lower gastrointestinal tract that selectively promotes the
growth of desirable (prebiotic) microflora and is associated
with a positive health outcome. Although there may be
exceptions, prebiotics tend to reduce populations of poten-
tially pathogenic flora while promoting desirable commen-
sals such as Bifidobacteria.
Recent evidence suggested that this effect might play an
important role in both the reduction in adiposity as well as a
decline in the contribution of adipocytes to inflammation. It
has been demonstrated in animal models that prebiotic sup-
plementation might reduce the development of large adipo-
cytes (those that predominate in the visceral compartment),
which are highly involved in the overactivation of a wide
variety of inflammatory processes associated with overeating,
obesity, diabetes, cardiovascular disease, and pain [32, 33].
Pathways of inflammation associated with atopic disease
may also be intimately associated with gut flora. Both pro-
biotics and prebiotics are believed to hold significant prom-
ise in the prevention and treatment of allergies and atopic
disorders, such as eczema [34–37], and they may have the
potential to play a significant role in the management of
inflammation as it relates to metabolic syndrome and other
obesity-related comorbidities such as nonalcoholic steatohe-
patosis [38, 39].
Lack of sufficient intake of prebiotics early in life may
have lasting ill effects on glucoregulation, which may result
in a substantial predilection toward obesity, diabetes, and
cardiovascular disease later in life [40]. Unfortunately, there
is little effort being made to increase fermentable soluble
fiber intake in infants and children. This may have serious
consequences and may be one of the many reasons for the
current obesity epidemic. The food industry has just begun
to respond to this with the introduction of prebiotic-fortified
infant formulas. Because breast milk contains significant
quantities of prebiotic oligosaccharides, adding analogous
agents to infant formulas would help these formulas to more
closely mimic breast milk. This strategy results in a gut flora
predominated by Bifidobacteria, rather than potential patho-
gens such as Clostridia and Enterobacter that tend to pre-
dominate in formula-fed infants [41]. There is now a
growing body of evidence that alterations in gut flora (eg,
a relative absence of Bifidobacteria) are significantly asso-
ciated with obesity [42]. In this regard, prebiotic fiber sup-
plementation may play a clinically important role in the
promotion of a more desirable gut microbiological milieu.
Neuroendocrine Effects of Fiber
One of the most intriguing and rapidly unfolding discoveries
is related to the role played by dietary fiber in the modula-
tion of important neuroendocrine physiology, which may be
related fundamentally to the etiology of obesity and related
conditions. Of particular interest is the impact of fiber on the
density and activity of a specialized enteroendocrine cell
known as the L cell [43]. The L cell is located throughout
the terminal ileum and colon, and it is responsible for the
secretion of the peptide hormones GLP-1, PYY, and oxy-
ntomodulin [44]. After a meal, oxyntomodulin and PYY are
released synchronously and they both act as potent anorexi-
gens. The rapid rise of these peptides signals a change in
energy status to the brain and it also acts locally to enhance
digestive and metabolic processes. GLP-1 is an incretin
hormone that also plays a pivotal role in glucoregulation
through the stimulation of accurately timed insulin secretion
and suppression of inappropriate glucagon secretion from
the pancreas. It has been established that diminished GLP-1
production plays a central role in the etiology of diabetes, a
discovery that has led to the development of an important
class of diabetes drugs, the incretin analogues. Augmenta-
tion of PYY and GLP-1 are thought to play a central role in
the regulation of the “ileal brake.” The ileal brake is a
Fig. 1 Comparison of pre-dinner mean hunger and prospective con-
sumption scores of day 3 of the 1000-calorie diet supplement with 5 g
of PGX or placebo at each meal. Values are mean±SE (n035). Asterisk
(*) indicates significantly lower scores with PGX than the placebo
supplement (P<0.05). VAS—visual analogue scale
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feedback mechanism that results in inhibition of proximal
gastrointestinal motility and secretion when nutrients and
nutrient metabolites arrive in sufficient quantities to the
luminal surface of the ileum. Animal and human studies
show that activation of the ileal brake by local perfusion
of the ileum with nutrients increases feelings of satiety and
reduces ad libitum food intake while slowing gastric and
proximal intestinal transit [45].
It has been recently shown that (bariatric) gastric bypass
surgery frequently results in rapid amelioration of diabetes
that often precedes significant weight loss [46]. Current
evidence points to a rapid and sustained increase in circu-
lating GLP-1 and PYY after this procedure that has pro-
found effects on appetite and glucoregulation. It is now
thought that the malabsorption of macronutrients and rapid
gastrointestinal transit after gastric bypass results in an in-
creased delivery of carbohydrates and their fermentation
products (SCFAs) as well as bile acids, both of which
activate L cells via free fatty acid (FFA) receptors and bile
acid receptors [47–51].
It is most interesting that fermentable soluble fiber has the
potential to generate a significant supply of SCFAs that might
mimic, on a lesser scale, the mechanism of gastric bypass
surgery through stimulation of FFA receptors with a resultant
increase in GLP-1 and PYY and augmenting the ileal brake
[52–54]. Viscous soluble fiber also effectively sequesters bile
acids, reducing their usual absorption through the jejunum
and delivering them to the same L cells where they stimulate
bile acid receptors. Thus, viscous soluble fiber that is also
fermentable may exert an appetite-reducing and glucoregulat-
ing effect through L-cell activation via both FFA receptors and
bile acid receptors as well as by suppression of the orexigenic
(appetite-stimulating) hormone ghrelin and augmentation of
CCK secretion [55–57].
Sequestration of bile acids by viscous soluble fiber is also
known to be a principle mechanism by which viscous fiber
lowers serum cholesterol, because sequestration of bile
acids decreases the enterohepatic recycling of bile acids, a
major cholesterol reservoir for the human [58].
Effect of Fiber on Postprandial Glycemia
Dietary recommendations for weight management usually in-
clude advice regarding the quantity of carbohydrates or the
percentage of daily calories from carbohydrate-containing
foods. A more meaningful recommendation might be based
upon the GI (the quantitative effect of a food on postprandial
glycemia) and the glycemic load (GL; themathematical product
of the GI and carbohydrate content). The GI of carbohydrate-
containing foods has long been known to be directly related to
the quantity and form of dietary fiber in the food [59]. Recently,
it has been verified that the GI and GL are more important
determinants of glycemic and insulinemic response than that of
carbohydrate intake alone [60, 61]. This may have profound
implications in the management of obesity and related con-
ditions. In diabetes, continuous glucose monitoring has
confirmed that GI and GL predict glycemic variability inde-
pendent from total carbohydrate intake [62].
Low GI-based diets have been shown to promote satiety
and reduce postprandial insulinemia [63]. However, the
evidence in favor of low GI/GL is inconsistent with many
weight loss studies showing only a trend in favor of this
approach [64]. Long-term adherence to a low GI diet may be
part of the problem in some studies. Regular use of viscous
fiber supplements may help obese subjects to consistently
achieve a lower GL while eating a diet that they can rea-
sonably maintain.
Maintenance of weight after weight loss interventions is
an elusive goal that has recently become the focus of several
important studies. The Diogenes (Diet, Obesity, and Genes)
study was designed to assess the efficacy of moderated fat
diets that vary in protein content and GI in the prevention of
weight regain and obesity-related risk factors after weight
loss [65••]. In this trial, the group maintained on the low GI
diet with moderately higher protein (25% of calories from
protein) had the highest compliance, the lowest dropout rate,
and was the only group that did not regain weight by the end
of the 26-week weight maintenance intervention period.
Data from the same study concluded that the low GI diets
also had a more substantial effect on the reduction of in-
flammation (as evidenced by C-reactive protein) than the
other diet interventions [66]. This finding is in keeping with
other studies pointing to a substantial benefit of dietary fiber
in the reduction of CRP, oxidative stress, and proinflamma-
tory cytokines [67–69].
The consistent addition of functional fiber supplements
to the diet may present a practical means to achieve
meaningful reductions in the GI/GL. Recently, our re-
search group was involved in several studies looking at
the effects of adding a novel, highly viscous functional
fiber supplement (PGX®) to various foods on GI, serum
cholesterol [71], hunger, and satiety in healthy humans
[26••, 71••, 72, 73••, 74, 75]. The novelty of this fiber
relates to its viscosity, which is higher than other fibers
thus studied and the fact that its viscosity slowly evolves
once hydrated. This allows consumption before palatabil-
ity is significantly affected. This viscous fiber is ferment-
able and prebiotic [76] and it is tasteless, and disperses
readily when added to food or mixed with beverages. Its
viscosity develops several minutes after initial hydration,
making it easy to consume the small amounts needed to create
a highly viscous and volumetric gastric milieu, leading to its
resultant physiologic effects.
In several studies, we have shown that the GI of food
can be substantially reduced with a small preload or
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intra-meal load of this highly viscous fiber [71••, 72,
73••, 75]. It has also been shown to promote satiety
and reduce subsequent food consumption [25••]. In a
human clinical trial, this novel viscous fiber has been
associated with an increase in the appetite-reducing
hormone PYY [77]. In studies of Zucker diabetic fatty
rats, the effects of diets supplemented with this highly
viscous fiber were compared with other dietary fibers.
Only the diet supplemented with the highly viscous
fiber substantially decreased postprandial blood glu-
cose and insulin secretion, decreased hepatic fatty in-
filtration, and preserved pancreatic β-cell mass [78].
These effects were accompanied by an increase in the
production of the glucoregulatory incretin hormone
GLP-1 [79].
Recommended Intake of Fiber for Weight Management
The dietary fiber intake for typical Americans is usually
less than desirable, with typical intakes averaging only 14
to 15 g/day and children consuming less than 5 g/day [4].
The American Dietetic Association currently recommends
that healthy adults should consume 20 to 35 g of fiber per
day and children should consume at least 5 g/day plus 1 g
for every year of their age [80]. They point out that
insoluble, nonfermentable, and low-viscosity fiber is prin-
cipally consumed to promote laxation and other aspects of
colon health, whereas viscous soluble fibers are necessary
to reduce serum cholesterol, blunt postprandial glycemic
response, and promote satiety. A fiber-rich meal, particu-
larly a meal high in viscous, soluble fiber, is processed
more slowly, promoting earlier satiety, and is frequently
less calorically dense and lower in fat and added sugars.
All of these characteristics are typical of a dietary profile
optimized to treat and prevent obesity. In one study, con-
sisting of 252 middle-aged women it was observed that
over a 20-month period participants lost an average of
4.4 lb in association with an 8-g increase in dietary fiber
per 1000 kcal [81]. Likewise, in a prospective cohort
study of nearly 30,000 men, a dose–response relationship
was found between fiber intake and weight gain over a
period of 8 years. They reported that for every 40-g/d
increase in whole-grain intake, weight gain decreased by
1.1 lb. Moreover, the addition of supplemental bran
seemed to play an important role in the reduction of
weight gain by 0.8 lb per 20 g/d intake [82]. Pal et al.
[83••] at Curtin University in Australia demonstrated the
utility of high-dose psyllium given as a premeal supple-
ment (12 g before each of 3 meals) as an adjunct to a
short-term, calorie-reduced weight loss program. Other
studies have demonstrated conflicting results from supple-
mental fiber in short-term weight management [71, 85].
Conclusions
Most clinicians in the field of obesity medicine agree that
dietary intervention for long-term weight management
should include practical eating strategies that promote and
maintain satiety to improve compliance and to minimize
discomfort in patients working to reduce energy intake. In
this regard, many clinicians now recommend volumetric,
low-calorie-density, low GL diets supplemented with mod-
erate amounts of protein. Increasing the intake of fiber by
consuming more high-fiber foods should play a central role
in this regard. These changes alone may not be sufficient to
bring about long-term weight reduction [85]. Supplementa-
tion of the diet with functional fiber supplements may sig-
nificantly augment high-fiber eating strategies by further
promoting satiety and reducing cardiometabolic risk factors.
Long-term clinical trials looking at the optimal form, quan-
tity, and frequency of dietary fiber supplements are greatly
needed to clarify their potential in the long-term manage-
ment of obesity.
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